Cargando…
LLDAS is an attainable treat-to-target goal in childhood-onset SLE
OBJECTIVES: To study whether clinical remission (CR) and Low Lupus Disease Activity State (LLDAS) are achievable goals in childhood-onset SLE. METHODS: Data on medication use and disease activity were prospectively collected. LLDAS was defined as Safety of Estrogen in Lupus Erythematosus National As...
Autores principales: | Wahadat, Mohamed Javad, van den Berg, Lotte, Timmermans, Demi, van Rijswijk, Kevin, van Dijk-Hummelman, Annette, Bakx, Susan, Verkaaik, Marleen, Versnel, Marjan A, Kamphuis, Sylvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719245/ https://www.ncbi.nlm.nih.gov/pubmed/34969874 http://dx.doi.org/10.1136/lupus-2021-000571 |
Ejemplares similares
-
Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort
por: Wahadat, M Javad, et al.
Publicado: (2022) -
Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study
por: Wahadat, Mohamed Javad, et al.
Publicado: (2023) -
Targeting DORIS Remission and LLDAS in SLE: A Review
por: Parra Sánchez, Agner R., et al.
Publicado: (2023) -
Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?
por: Wahadat, M. Javad, et al.
Publicado: (2018) -
Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study
por: Wahadat, M Javad, et al.
Publicado: (2022)